Neurovascular disorders are recognized among one of the deadliest diseases, accounting for an alarming global toll of approximately 15 million new cases annually. At present, several conventional methods, such as open neurosurgery, microsurgery and bypass surgery are available for treating such conditions. However, these approaches often impose several complications such as disruption of normal vasculature and high chances of disease recurrence, owing to their highly invasive treatment approach. In order to address this, neurovascular devices emerged as a possible regime, which utilizes minimally invasive and more site-specific techniques. The concept of neurovascular devices holds significant potential in treating neurovascular disorders by shifting away from a highly invasive and complicated approaches.

The global neurovascular devices market size is projected to grow from $3,325 million in 2024 to $7,011 million by 2035, representing a CAGR of 7.02%, during the forecast period, till 2035.

The neurovascular devices have attracted significant attention, owing to their higher success rate in improving life expectancy and patient care outcomes. Neurovascular devices encompasses intracranial stents, embolic clippings, aspiration devices, balloon catheters and accessory devices. It is worth highlighting that neurovascular devices have been considered as the next generation of treatment for neurovascular disorders, owing to their minimal side effects, faster recovery, high success rates and positive patient outcomes. With Continuous research efforts and innovation in this field and rising interest of investors in this domain, the neurovascular devices market is anticipated to experience significant market growth over the forecasted period.

ADVANTAGES OF NEUROVASCULAR DEVICES

Site-Specific Treatment:  Conventional treatment options are more likely to impose the risk of normal vasculature disruption and delayed recovery rates. In such cases, neurovascular devices helps in precise and targeted treatment to a specific site of the brain.

Reduced Complications: Neurovascular Devices tailors a site-specific treatment based on the type of neurovascular disease treated. The patients receive targeted and minimally invasive treatment, thereby reducing the possible side effects and complications associated with the conventional surgical approaches. 

High Success Rate: Neurovascular devices have demonstrated high success rate (>60%) in treatment of neurovascular disorders. Such exceptional results have piqued the interest of various device developers to enhance their research efforts in improving their product portfolio. Notably, around 310 neurovascular devices have been approved and launched in the market for the treatment of different types of neurovascular disorders.

THE FUTURE OF NEUROVASCULAR DEVICES

The concept of neurovascular devices holds immense potential to transform the treatment approaches for neurovascular disorders. The integration of various advanced technologies have facilitated the smooth transition of neurovascular devices from research to clinical application. However, owing to the complex pathophysiology of various neurovascular disorders, researchers are still in the early phases of developing neurovascular disease specific devices and translating it with a technology to reach the most torturous cerebral regions. As a result, there is a need to create advanced technologies that modify the device necessary to make accurate therapeutic inferences and positive patient outcomes. Additionally, to gain insights into the operational techniques of neurovascular devices, it is essential to gain a more comprehensive understanding of the pathological mechanisms associated with the various neurovascular disorders. Several advancements, such as drug-coated devices, personalized devices and conjunctive devices are necessary to revolutionize the next-generation neurovascular devices, which helps healthcare professionals in ensuring positive outcomes based on the higher success rates and faster recovery. A collaborative effort among all stakeholders in the healthcare industry is likely to expedite the accomplishment of these future goals marking a pivotal milestone in the neurovascular devices domain.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/neurovascular-devices-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.             

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact Details

Roots Analysis 

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com 

Website: https://www.rootsanalysis.com/